These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6800076)

  • 1. Sickle cell trait and the immune response to meningococcal vaccines.
    Blakebrough IS; Greenwood BM; Whittle HC; Bradley AK; Akintunde A
    Trans R Soc Trop Med Hyg; 1981; 75(6):905-6. PubMed ID: 6800076
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria.
    Mohammed I; Damisah MM
    Trans R Soc Trop Med Hyg; 1982; 76(3):351-3. PubMed ID: 6810520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the immune response to vaccination after acute malaria.
    Williamson WA; Greenwood BM
    Lancet; 1978 Jun; 1(8078):1328-9. PubMed ID: 78096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of antibody to hepatitis B surface antigen in sickle cell trait.
    Kujwalile JM; Kigoni EP; Nhonoli AM
    East Afr Med J; 1980 Nov; 57(11):751-4. PubMed ID: 7215260
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
    Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
    J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of meningococcal antibodies by microassay.
    Ambrosch F; Stemberger H; Wiedermann G; Stanek G; Jovanovic D
    Bull World Health Organ; 1978; 56(5):787-90. PubMed ID: 104795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.
    Gold R; Lepow ML; Goldschneider I; Gotschlich EC
    J Infect Dis; 1977 Aug; 136 Suppl():S31-5. PubMed ID: 408431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Plasmodium falciparum infection in children with hemoglobin S.
    Gendrel D; Kombila M; Nardou M; Gendrel C; Djouba F; Richard-Lenoble D
    Pediatr Infect Dis J; 1991 Aug; 10(8):620-1. PubMed ID: 1891293
    [No Abstract]   [Full Text] [Related]  

  • 16. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
    Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
    Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
    [No Abstract]   [Full Text] [Related]  

  • 17. Reimmunization to pneumococcus in patients with sickle cell disease: do they or don't they respond?
    Rao SP; Rajkumar K; Schiffman G; Unger C
    J Pediatr; 1997 Sep; 131(3):498-9. PubMed ID: 9329440
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased expression in erythrocytic Ii antigens in sickle cell disease and sickle cell trait.
    Maniatis A; Frieman B; Bertles JF
    Vox Sang; 1977 Jul; 33(1):29-36. PubMed ID: 883243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulins in sickle cell disease.
    Mohapatra BN; Dash BP; Kar BC
    J Assoc Physicians India; 1993 Jul; 41(7):418-9. PubMed ID: 8300484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine.
    Milagres LG; Gorla MC; Rebelo MC; Barroso DE
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):319-27. PubMed ID: 10891656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.